Results 261 to 270 of about 6,936,245 (306)
Some of the next articles are maybe not open access.
Production of extracellular lactase fromFusarium moniliforme
European Journal of Applied Microbiology and Biotechnology, 1981A strain ofFusarium moniliforme, previously used for microbial protein production, excreted lactase (β-D-galactosidase, EC.3.2.1 23) when cultivated either in a whey liquid medium or on a wheat bran solid medium. The enzyme produced in both media had pH and temperature optima of 4–5 and 50–60°C respectively and was particularly suitable for processing ...
openaire +1 more source
Extracellular Protease Production by B. Amyloliquefaciens
1987B. amyloliquefaciens produces large amounts of two major secretory proteases: alkaline protease and neutral protease. Protease production by this organism is very unusual in its response to inhibitors of transcription. Using the antibiotics rifampicin and actinomycin D, which block transcription, we have demonstrated the presence of an apparent mRNA ...
M. J. Bawden +4 more
openaire +1 more source
Extracellular products from Chlorococcum ellipsoideum and Chlamydomonas globosa
Archiv f�r Mikrobiologie, 1972Extracellular products of Chlorococcum and Chlamydomonas were isolated from culture filtrates. Five groups of substances were found in both species: (i) steam-volatile acids, (ii) yellow water-soluble phenolic compounds, (iii) lipophilic substances, (iv) proteins and (v) polysaccharides.
openaire +2 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
[Extracellular-superoxide dismutase production in mesangial cell growing in extracellular matrix].
Nihon Jinzo Gakkai shi, 2005To study the protective function against oxygen radicals in the mesangial area, we assessed extracellular superoxide dismutase (EC-SOD) production in mesangial cells (MCs) in vitro. These cells have a major protective function against oxygen radicals in the extracellular space.
Harutaka, Yamada +12 more
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Natural products in drug discovery: advances and opportunities
Nature Reviews Drug Discovery, 2021Atanas G Atanasov +2 more
exaly

